The agency sets a   goal for approving standard drugs, and a   period for those that have qualified for expedited approval one recent study showed it decides on drugs more quickly than its counterparts in Europe and Canada. A majority of recent new drugs were approved through expedited approvals, another recent study found. In December, Congress passed a law that further speeds approvals for certain drugs and medical devices. Drug industry leaders say that they want the F. D. A. to be more open to allowing new kinds of clinical trials, and that it needs to become more nimble in keeping up with the breathtaking pace of medical advances. 